Entry Detail



General Information

Database ID:exR0359280
RNA Name:ACADSB
RNA Type:mRNA
Chromosome:chr10
Starnd:+
Coordinate:
Start Site(bp):123008979End Site(bp):123058290
External Links:ENSG00000196177



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
B2M
chr15
44711487
44718877
+
B4GAT1
chr11
66345374
66347629
-
BUB3
chr10
123154402
123170467
+
C11orf58
chr11
16613132
16758340
+
CCND2
chr12
4273762
4305353
+
COX18
chr4
73052362
73069755
-
DDX24
chr14
94048287
94081212
-
DHCR24
chr1
54849627
54887195
-
EIF4E
chr4
98871684
98930637
-
HLA-B
chr6
31269491
31357188
-
MCFD2
chr2
46901870
46941855
-
MICB
chr6
31494881
31511124
+
NCOR1
chr17
16029157
16218185
-
NFATC3
chr16
68084751
68229259
+
NOP53
chr19
47745546
47757058
+
POGK
chr1
166839447
166856344
+
POLE3
chr9
113407235
113410675
-
RFFL
chr17
35005990
35089319
-
TPT1
chr13
45333471
45341370
-
VMP1
chr17
59707192
59842255
+
YWHAE
chr17
1344275
1400222
-
YWHAQ
chr2
9583967
9630997
-
ZNF100
chr19
21722771
21767579
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.